GO:0072540 T-helper 17 cell lineage commitment: Lineage Specification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072540 describes the developmental process by which a naive CD4+ T cell commits to the T-helper 17 (Th17) lineage, a fate distinct from Th1 and Th2 lineages.
• Th17 commitment is driven by the master transcription factor RORγt (RORC) together with STAT3 and IRF4, and is stabilized by IL-23 signaling.
• The process is initiated by TGF-β plus IL-6 (and IL-21/IL-23) and involves epigenetic remodeling at lineage-defining loci.
• Th17 cells are defined by production of IL-17A, IL-17F, IL-21 and IL-22 and are central to mucosal immunity and autoimmunity.
• Dysregulated Th17 commitment contributes to psoriasis, inflammatory bowel disease, multiple sclerosis and graft-versus-host disease.
• CRISPR knockout, knock-in and overexpression models enable causal dissection of Th17 lineage commitment genes.
Description
T-helper 17 (Th17) cell lineage commitment (GO:0072540) is the biological process through which a naive CD4+ T lymphocyte acquires the transcriptional and epigenetic program of the Th17 effector lineage. It was first defined as a lineage distinct from Th1 and Th2 cells by Harrington and colleagues, who showed that IL-17-producing CD4+ effector T cells develop via a separate developmental pathway. This process is essential for host defense against extracellular bacteria and fungi at mucosal surfaces and is a major driver of autoimmune and inflammatory pathology. Understanding GO:0072540 therefore matters for immunologists studying T-cell differentiation, for translational researchers targeting IL-17/IL-23 in disease, and for groups using CRISPR screens to identify novel regulators of T-cell fate. The term encompasses the cytokine signals, transcription-factor networks and epigenetic changes that together commit a CD4+ T cell to the Th17 program.
T-helper 17 cell lineage commitment At A Glance
| GO ID | GO:0072540 |
|---|---|
| GO term | T-helper 17 cell lineage commitment |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Commitment of CD4+ T cells to the Th17 effector lineage |
| Key cytokines | TGF-β, IL-6, IL-21, IL-23 |
| Key transcription factors | RORγt (RORC), STAT3, IRF4, BATF |
| Hallmark output | IL-17A, IL-17F, IL-21, IL-22 production |
| Disease relevance | Autoimmunity, mucosal immunity, GVHD |
What Is GO:0072540?
GO:0072540 (T-helper 17 cell lineage commitment) is a biological process term describing the commitment of a CD4+ T helper cell to the Th17 lineage. In practice, this means the cell transitions from a naive state to a state in which it expresses the Th17 master regulator RORγt, produces IL-17 family cytokines, and is epigenetically poised to maintain that identity. The process is triggered by cytokine signals (TGF-β, IL-6, IL-21, IL-23) and executed by lineage-defining transcription factors such as RORγt, STAT3 and IRF4.
Why Is T-helper 17 cell lineage commitment Important in Cell Biology?
Th17 lineage commitment is important because it determines whether a CD4+ T cell becomes a protective mucosal effector or a pathogenic driver of chronic inflammation. The IL-23–IL-17 axis that depends on this commitment is a validated therapeutic target in psoriasis, psoriatic arthritis, ankylosing spondylitis and inflammatory bowel disease. Because lineage-defining transcription factors are potent and specific regulators of T-cell fate, they are attractive targets for therapies aimed at graft-versus-host disease and autoimmune conditions. Studying GO:0072540 also provides a paradigm for how cytokine signals, transcription factors and epigenetic silencing cooperate to establish a stable cell fate.
• Defines a CD4+ T-cell fate distinct from Th1 and Th2 lineages.
• Controls production of IL-17A, IL-17F, IL-21 and IL-22.
• Central to host defense against extracellular bacteria and fungi at mucosal barriers.
• Drives pathogenesis of psoriasis, IBD, multiple sclerosis and other autoimmune diseases.
• IL-23 signaling stabilizes and maintains the committed Th17 phenotype.
• Lineage-defining transcription factors are candidate targets for GVHD therapy.
• Epigenetic silencing pathways shape Th lineage commitment decisions.
• Helicase A has been shown to determine the transcriptional program of Th17 differentiation and autoimmunity.
• Provides a model for studying cytokine-driven transcription factor networks.
• Enables CRISPR-based causal screens for novel Th17 regulators.
What Happens During T-helper 17 cell lineage commitment?
Cytokine priming of naive CD4+ T cells
In simple terms: Cytokines in the environment tell a naive T cell which fate to choose.
Commitment begins when a naive CD4+ T cell receives cytokine signals, classically TGF-β plus IL-6, and later IL-21 and IL-23, which together initiate the Th17 program. These signals are distinct from the IFN-γ/IL-12 and IL-4 cues that drive Th1 and Th2 commitment, establishing Th17 as a separate lineage.
Activation of lineage-defining transcription factors
In simple terms: Master transcription factors switch on the Th17 gene program.
Cytokine signaling activates STAT3, which together with IRF4 and BATF induces the master regulator RORγt (RORC). RORγt is the lineage-defining transcription factor for Th17 cells and is required for expression of IL-17A, IL-17F and IL-22. Lineage-defining transcription factors such as these are potent and specific determinants of T helper fate.
Epigenetic remodeling and lineage stabilization
In simple terms: The cell locks in its new identity by changing how DNA is packaged.
Commitment involves epigenetic changes at lineage-defining loci, including DNA methylation and histone modifications that stabilize the Th17 program and silence alternative fates. An epigenetic silencing pathway has been shown to control T helper 2 lineage commitment, illustrating how epigenetic mechanisms shape T helper fate decisions more broadly. Helicase A has been reported to determine the transcription program of Th17 lineage differentiation and autoimmunity.
Maintenance by IL-23 signaling
In simple terms: A cytokine called IL-23 keeps the Th17 cell committed and active.
After initial commitment, IL-23 signaling through the IL-23 receptor sustains RORγt expression and effector cytokine production, stabilizing the Th17 phenotype. The IL-23–IL-17 immune axis is the functional output of committed Th17 cells and is a validated therapeutic target.
Effector cytokine production and function
In simple terms: The committed cell now secretes cytokines that recruit other immune cells.
Committed Th17 cells produce IL-17A, IL-17F, IL-21 and IL-22, which act on epithelial and stromal cells to induce antimicrobial peptides and recruit neutrophils. IL-17RA signaling in intestinal stem cells can induce ATOH1 and promote secretory lineage commitment, illustrating how Th17-derived cytokines shape tissue responses.
Key Genes Involved in GO:0072540 T-helper 17 cell lineage commitment
The following genes and proteins are central to T-helper 17 cell lineage commitment and are commonly studied in CRISPR models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RORC | Master transcription factor (RORγt) of Th17 lineage | Defines Th17 identity; KO abolishes IL-17 production |
| STAT3 | Signal transducer downstream of IL-6/IL-23 | Required for RORγt induction; KO blocks Th17 commitment |
| IRF4 | Transcription factor cooperating with STAT3/BATF | Promotes Th17 differentiation |
| BATF | Transcription factor partnering with IRF4 | Supports Th17 gene program |
| IL6 | Cytokine initiating Th17 priming | Essential for initial commitment |
| IL21 | Cytokine amplifying Th17 differentiation | Autocrine amplification of Th17 program |
| IL23A | Cytokine stabilizing committed Th17 cells | Maintains IL-17 production |
| IL23R | Receptor for IL-23 | Sustains RORγt and effector function |
| IL17A | Effector cytokine hallmark of Th17 cells | Readout of commitment |
| IL17F | Effector cytokine co-expressed with IL-17A | Readout of commitment |
| IL17RA | Receptor mediating IL-17 signaling | Links Th17 to tissue responses |
| TGFB1 | Cytokine required for Th17 priming | Cooperates with IL-6 |
| BCL6 | Transcription factor directing Tfh lineage | Contrasts with Th17 fate choice |
| ATOH1 | Transcription factor downstream of IL-17RA | Links Th17 cytokines to epithelial lineage commitment |
| FOXP3 | Regulatory T cell master factor | Alternative fate to Th17 |
| TBX21 | Th1 master transcription factor | Alternative fate to Th17 |
| GATA3 | Th2 master transcription factor | Alternative fate to Th17 |
How Is T-helper 17 cell lineage commitment Regulated?
Th17 lineage commitment is regulated by a balance of cytokine signals and transcription factors. TGF-β plus IL-6 initiate the program, while IL-21 amplifies it and IL-23 stabilizes the committed state. STAT3 activation is a key node, and RORγt acts as the lineage-defining transcription factor. Epigenetic silencing pathways also control T helper lineage commitment decisions, indicating that chromatin-level regulation is integral to the process. Helicase A has been identified as a determinant of the Th17 transcriptional program and autoimmunity.
T-helper 17 cell lineage commitment and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RORC | Psoriasis, autoimmune inflammation | Knockout and knock-in in primary CD4+ T cells |
| IL23R | Inflammatory bowel disease, psoriasis | Point mutation knock-in to test signaling variants |
| STAT3 | Autoimmunity, immunodeficiency | Knockout in T cells to block Th17 commitment |
| IL17A | Psoriasis, ankylosing spondylitis | Overexpression and knockout in T cells |
| ATOH1 | Intestinal epithelial lineage commitment | Knockout in intestinal stem cells |
Autoimmune and inflammatory diseases
Dysregulated Th17 commitment and IL-17 production contribute to psoriasis, psoriatic arthritis, ankylosing spondylitis, inflammatory bowel disease and multiple sclerosis. The IL-23–IL-17 axis is a validated therapeutic target, and drugs blocking IL-17 or IL-23 are used clinically.
Graft-versus-host disease
T helper lineage-defining transcription factors, including those controlling Th17 commitment, are potent and specific targets for graft-versus-host disease therapy. Modulating Th17 commitment may help separate beneficial immunity from pathogenic alloreactivity.
Mucosal immunity and barrier function
Th17 cells are essential for mucosal host defense, and IL-17RA signaling in intestinal stem cells can induce ATOH1 to promote secretory lineage commitment, linking Th17 immunity to epithelial regeneration.
Autoimmunity and transcriptional control
Helicase A determines the transcription program of Th17 lineage differentiation and autoimmunity, highlighting how transcriptional regulators of GO:0072540 can influence autoimmune disease.
From T-helper 17 cell lineage commitment-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for Th17 commitment? | CRISPR knockout in primary CD4+ T cells |
| Does a disease-associated variant alter Th17 differentiation? | Point mutation knock-in |
| Can a transcription factor reporter track Th17 fate? | Tagged knock-in of RORC or IL17A |
| Does overexpression drive Th17 commitment? | Overexpression of RORC or STAT3 |
| Which epigenetic regulators control Th17 fate? | Knockout of epigenetic modifiers |
| Which novel genes regulate Th17 differentiation? | CRISPR library screening |
How to Study the T-helper 17 cell lineage commitment Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | IL-17A/IL-17F and RORγt protein levels | Quantify Th17 commitment |
| RNA-seq | Transcriptome changes during differentiation | Define Th17 gene program |
| ATAC-seq / ChIP-seq | Chromatin accessibility and factor binding | Map epigenetic remodeling |
| DNA methylation analysis | Methylation at lineage loci | Assess epigenetic silencing |
| CRISPR knockout | Gene requirement for Th17 commitment | Causal validation of candidates |
| CRISPR library screen | Genome-wide regulators of Th17 fate | Discovery of novel genes |
| Cytokine ELISA | Secreted IL-17A/IL-17F | Functional readout of commitment |
| Reporter knock-in | Live tracking of RORC or IL17A expression | Fate mapping and sorting |
Flow cytometry and cytokine readouts
Intracellular staining for IL-17A and IL-17F, together with RORγt detection, is the standard readout for Th17 commitment. These assays quantify the proportion of cells that have acquired the Th17 effector program.
Transcriptional profiling
RNA-seq of polarized CD4+ T cells identifies genes induced or repressed during Th17 commitment, including RORC, IL17A and IL17F. Comparative profiling across Th1, Th2 and Th17 conditions defines lineage-specific signatures.
Epigenetic assays
DNA methylation and histone modification analyses at lineage-defining loci reveal how epigenetic silencing pathways control T helper lineage commitment. These methods show how chromatin states stabilize the Th17 program.
CRISPR screening and functional genomics
Pooled CRISPR screens in primary T cells or T-cell lines can identify novel regulators of Th17 differentiation and IL-17 production. Hits are validated by individual knockout and cytokine readouts.
How CRISPR Can Be Used to Study GO:0072540 T-helper 17 cell lineage commitment
Knockout
CRISPR knockout of RORC, STAT3 or IRF4 in primary CD4+ T cells abolishes Th17 commitment and IL-17 production, providing causal evidence for their roles. Knockout screens can identify additional required genes.
Point Mutation
Point mutation knock-in can model disease-associated variants in genes such as IL23R or STAT3 to test their effect on Th17 differentiation and IL-17 output. This approach links genetic variants to lineage commitment phenotypes.
Knock-in
Tagged knock-in of RORC or IL17A enables reporter-based tracking of Th17 commitment and isolation of committed cells. Knock-in of epitope tags facilitates chromatin and protein interaction studies.
Overexpression
Overexpression of RORC or STAT3 can drive Th17 commitment even under suboptimal cytokine conditions, testing sufficiency of individual factors. Overexpression models help dissect the transcriptional network controlling GO:0072540.
How EDITGENE Supports T-helper 17 cell lineage commitment Research
Researchers studying T-helper 17 cell lineage commitment-related genes often need to determine whether a candidate gene is causally involved in Th17 differentiation, whether a disease-associated variant alters lineage commitment, or whether a transcription factor is sufficient to drive the Th17 program. EDITGENE provides the CRISPR tools and services required to answer these questions in primary T cells and model systems.
Contact EDITGENE today to design your custom CRISPR model for T-helper 17 cell lineage commitment research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| IL6ST Knockout HEK293 Cell Line | EDJ-KQ134 | Human | 3572 | Details Get a Quote |
| IL6 Knockout HEK293 Cell Line | EDJ-KQ498 | Human | 3569 | Details Get a Quote |
| IL6R Knockout HEK293 Cell Line | EDJ-KQ499 | Human | 3570 | Details Get a Quote |
| SOCS3 Knockout HEK293 Cell Line | EDJ-KQ527 | Human | 9021 | Details Get a Quote |
| STAT3 Knockout HEK293 Cell Line | EDJ-KQ903 | Human | 6774 | Details Get a Quote |
| IRF4 Knockout HEK293 Cell Line | EDJ-KQ3195 | Human | 3662 | Details Get a Quote |
| LY9 Knockout HEK293 Cell Line | EDJ-KQ4378 | Human | 4063 | Details Get a Quote |
| BATF Knockout HEK293 Cell Line | EDJ-KQ7088 | Human | 10538 | Details Get a Quote |
| SLAMF6 Knockout HEK293 Cell Line | EDJ-KQ7479 | Human | 114836 | Details Get a Quote |
| JAK1 Knockout HEK293 Cell Line | EDJ-KQ17827 | Human | 3716 | Details Get a Quote |
| STAT3 Knockout HeLa Cell Line | EDJ-KQ18072 | Human | 6774 | Details Get a Quote |
| STAT3 Knockout A-549 Cell Line | EDJ-KQ21087 | Human | 6774 | Details Get a Quote |
| STAT3 Knockout HCT 116 Cell Line | EDJ-KQ21089 | Human | 6774 | Details Get a Quote |
| IL6 Knockout A-549 Cell Line | EDJ-KQ18810 | Human | 3569 | Details Get a Quote |
| IL6 Knockout HeLa Cell Line | EDJ-KQ18811 | Human | 3569 | Details Get a Quote |
Displaying Records 1 To 15 Of 47 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About T-helper 17 cell lineage commitment
What is GO:0072540?
GO:0072540 is the Gene Ontology biological process term for T-helper 17 cell lineage commitment, the process by which a CD4+ T cell commits to the Th17 fate.
What is T-helper 17 cell lineage commitment?
It is the developmental process in which a naive CD4+ T cell acquires the Th17 transcriptional program, expresses RORγt and produces IL-17 family cytokines.
What genes are involved in T-helper 17 cell lineage commitment?
Key genes include RORC, STAT3, IRF4, BATF, IL6, IL21, IL23R, IL17A and IL17F.
Which transcription factor defines Th17 cells?
RORγt, encoded by RORC, is the master lineage-defining transcription factor for Th17 cells.
How is Th17 commitment different from Th1 and Th2 commitment?
Th17 commitment develops via a lineage distinct from Th1 and Th2 lineages, with different cytokines and transcription factors.
What cytokines drive Th17 differentiation?
TGF-β plus IL-6 initiate Th17 differentiation, while IL-21 amplifies and IL-23 stabilizes the committed state.
What diseases are linked to Th17 cells?
Th17 cells and the IL-23–IL-17 axis are linked to psoriasis, inflammatory bowel disease, multiple sclerosis and graft-versus-host disease.
How do epigenetic changes affect Th17 commitment?
Epigenetic silencing pathways and chromatin remodeling at lineage-defining loci stabilize T helper lineage commitment decisions.
How can CRISPR be used to study Th17 lineage commitment?
CRISPR knockout, knock-in, point mutation and overexpression models can test the requirement or sufficiency of candidate genes for Th17 differentiation.
What methods measure Th17 commitment?
Flow cytometry for IL-17A and RORγt, RNA-seq, epigenetic assays and cytokine ELISA are commonly used.
Conclusion
GO:0072540 T-helper 17 cell lineage commitment is a well-defined biological process that integrates cytokine signals, lineage-defining transcription factors and epigenetic remodeling to establish the Th17 fate. Its importance spans mucosal immunity, autoimmunity and transplantation, making it a high-value target for mechanistic and translational research. CRISPR-based knockout, knock-in, point mutation, overexpression and library screening approaches provide the causal tools needed to dissect this process and identify new therapeutic opportunities.
References
- 1. Harrington LE et al.. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.. Nat Immunol 6(11):1123-32 PMID: 16200070
- 2. Gaffen SL et al.. 2014. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing.. Nat Rev Immunol 14(9):585-600 PMID: 25145755
- 3. Lin X et al.. 2022. IL-17RA-signaling in Lgr5(+) intestinal stem cells induces expression of transcription factor ATOH1 to promote secretory cell lineage commitment.. Immunity 55(2):237-253.e8 PMID: 35081371
- 4. Campe J et al.. 2021. T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?. Front Immunol 12:806529 PMID: 35069590
- 5. Yu D et al.. 2009. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment.. Immunity 31(3):457-68 PMID: 19631565
- 6. Allan RS et al.. 2012. An epigenetic silencing pathway controlling T helper 2 cell lineage commitment.. Nature 487(7406):249-53 PMID: 22763435
- 7. Su Y et al.. 2026. Helicase A determines the transcription program of T(H)17 lineage differentiation and autoimmunity.. Sci Adv 12(20):eaeb9679 PMID: 42139358
- 8. Janson PC et al.. 2009. At the crossroads of T helper lineage commitment-Epigenetics points the way.. Biochim Biophys Acta 1790(9):906-19 PMID: 19162128
